Sleep has been shown to play a crucial role in the consolidation of emotionally salient memories. However, the influence of sleep, and Sleep Deprivation (SD), on emotional memory consolidation in depressive individuals remains elusive. For this experiment we recruited two groups of healthy students, one reporting mild-to-severe depressive symptoms, and another reporting minimal/no depressive symptoms (assessed using the Beck Depression Inventory; BDI-II). We measured recognition performance for positive, neutral and negative images before and after a 12 h overnight retention interval, during which participants either remained awake in the laboratory or returned home to sleep normally. We found a significant depressive symptomatology group × sleep condition × image valence interaction on memory consolidation across the 12 h retention interval [F(2, 98) = 3.12, p = .049, η p 2 = 0.060]. We also found that depressive participants who slept normally consolidated significantly more negative and neutral images across the 12 h retention interval than depressive participants who were sleep deprived [t(24) = 2.35, p = .028, t(24) = 2.79, p = .010, respectively]. Our preliminary results indicate that SD may impair the consolidation of negative and neutral memories in depressive participants, but not in participants reporting minimal/no depressive symptoms.
Introduction
Individuals reporting symptoms of depression such as despair and hopelessness exhibit greater recall and recognition performance for negative emotional stimuli, relative to individuals reporting minimal/ no depressive symptoms (Everaert, Duyck, & Koster, 2014; Fattahi Asl, Ghanizadeh, Mollazade, & Aflakseir, 2015; Howe & Malone, 2011) . This emotional memory bias may increase vulnerability to the development and recurrence of Major Depressive Disorder (MDD; Beck, 1967; Everaert, Koster, & Derakshan, 2012; Gotlib & Joormann, 2010) . In healthy participants, emotionally salient memories are better remembered than their neutral or mundane counterparts (Kensinger, 2004; McGaugh, 2004) . Emotionally enhanced memory may be facilitated by sleep, which selectively consolidates memories which elicit emotional arousal (Payne, Chambers, & Kensinger, 2012; Payne, Stickgold, Swanberg, & Kensinger, 2008) .
Empirical evidence suggests that Rapid Eye Movement (REM) sleep, in particular, plays a crucial role in the consolidation of emotional memories (Groch, Zinke, Wilhelm, & Born, 2015; Nishida, Pearsall, Buckner, & Walker, 2009; Payne et al., 2012; Wagner, Gais, & Born, 2001; Wiesner et al., 2015) . For example, in healthy students selective REM Sleep Deprivation (SD) has been shown to impair the consolidation of negative emotional images, but not emotionally neutral images, to a greater extent than selective Slow-Wave Sleep (SWS) deprivation (Wiesner et al., 2015) . Furthermore, correlational analyses reveal that, for healthy individuals, greater consolidation of emotionally negative images is predicted by longer duration of time spent in REM sleep during retention intervals (Nishida et al., 2009; Payne et al., 2012) . Similarly, split-night studies in healthy participants have shown that 3 h of late night REM-rich sleep fosters the selective consolidation of emotionally negative stimuli more abundantly than 3 h of early night sleep where REM sleep is less plentiful (Groch et al., 2015; Wagner et al., 2001) . Importantly, although it is clear that REM sleep is centrally involved in emotional memory consolidation, SWS has also been shown to contribute to this process in some studies (e.g. Cairney, Durrant, Power, & Lewis, 2015; Groch et al., 2011) . Moreover, contrary to the bulk of the existing literature, some investigations have failed to detect a specific role for REM sleep in emotional memory consolidation (Ackermann, Hartmann, Papassotiropoulos, de Quervain, & Rasch, 2015; Cellini, Torre, Stegagno, & Sarlo, 2016; Morgenthaler et al., 2014) .
Experiments investigating the relationship between sleep and memory in depressive participants have mostly shown that sleep-associated consolidation is impaired in MDD patients. For example, healthy controls have been shown to exhibit greater overnight improvements on a motor memory task than MDD patients (Dresler et al., 2011; Dresler, Kluge, Genzel, Schüssler, & Steiger, 2010; Nishida, Nakashima, & Nishikawa, 2016) . Moreover, MDD patients who performed poorly on a declarative visual memory task exhibited shorter REM sleep duration and total sleep time than patients who performed well on the task (Göder et al., 2007) . The association between sleep and emotional memory in depressive participants has received comparatively less empirical attention. Nonetheless, we recently revealed that late night REM-rich sleep promotes the consolidation of negative emotional images more readily in participants reporting mild-to-moderate depressive symptoms than participants reporting minimal/no symptoms of depression (Harrington, Johnson, Croom, Pennington, & Durrant, 2018) .
The current study aimed to investigate the short-and long-term effect of post-learning sleep, or SD, on recognition performance for positive, neutral and negative images in samples of healthy participants reporting either minimal/no depressive symptoms or mild-to-severe depressive symptoms. These two groups of participants are referred to below as the low Beck Depression Inventory (BDI-II) score group and the higher BDI-II score group, respectively. Although it has been shown that SD, and selective REM SD, impairs the consolidation of emotionally negative information in healthy participants (Tempesta, De Gennaro, Natale, & Ferrara, 2015; Wiesner et al., 2015) ; the effect of SD on emotional memory consolidation in participants reporting depressive symptoms remains unexplored. We predicted that SD would impair the consolidation of negative emotional memories, and that this effect would be more robust in the higher BDI-II score group than the low BDI-II score group.
Materials and methods

Participants
Recruitment was based on BDI-II (Beck, Steer, & Brown, 1996) scores obtained from a prescreen of 128 student volunteers who signed up using an online research participation system. Fifty-six participants were selected based on their prescreen BDI-II scores and assigned to one of two depressive symptomatology groups: a low BDI-II score group and a higher BDI-II score group (see Section 2.1.1 for group criteria). Both depressive symptomatology groups were then randomly sub-divided into a further two separate sleep condition groups, a Sleep Deprivation (SD) condition and a Normal Sleep (NS) condition (see Section 2.3 for information about sleep conditions). Participants were required to have no history of sleep, neurological, endocrine or psychiatric disorders as assessed through self-report. Participants were also free of long-term medication (except for the female contraceptive pill), and were native English speakers.
Of the selected participants, two were excluded from final analyses for failing to meet the eligibility criteria at the first subsequent test session (i.e. they were originally assigned to the higher BDI-II score group, but reported a BDI-II score below the cut-off boundary for this group at the first subsequent test session). Data is reported from the remaining 54 participants (see Table 1 ): 14 in the higher BDI-II score SD group (four male, ten female) aged 19-23, 12 in the higher BDI-II score NS group (three male, nine female) aged 18-23, 14 in the low BDI-II score SD group (six male, eight female) aged 18-22, and 14 in the low BDI-II score NS group (four male, ten female) aged 18-25.
Participants were asked to abstain from alcohol, caffeine, and other drugs for 24 h prior to test sessions. Participants were rewarded for their participation with course credits. Each participant gave informed consent for this study, which was approved by the School of Psychology Research Ethics Committee at the University of Lincoln.
Depressive symptomatology groups
The BDI-II measures depressive symptom severity with 21 items rated on a scale from zero to three. This self-report measure has good reliability and validity in both healthy and depressed samples (Beck et al., 1996) and is widely used in cognitive research (Everaert et al., 2014; Hindash & Amir, 2011; Newby, Lang, Werner-Seidler, Holmes, & Moulds, 2014) . Prescreen data showed that BDI-II scores ranged from zero to 52, with 92 individuals reporting minimal/no (BDI-II cut off range: 0-13), 16 mild (BDI-II cut off range: 14-19), 13 moderate (BDI-II cut off range: 20-28), and seven severe symptom levels (BDI-II cut off range: 29-63). We invited individuals reporting BDI-II scores ≥14, and a matching number of individuals who reported the lowest BDI-II scores at the prescreen, to participate in this study. Individuals who accepted our invitation, reported BDI-II scores ≤13 at both the prescreen and the first test session, and successfully completed the study, make up the low BDI-II score group (BDI-II score: mean = 2.14, range = 0-6). Individuals who accepted our invitation, reported BDI-II scores ≥14 at both the prescreen and the first test session, and successfully completed the study, make up the higher BDI-II score group (BDI-II score: mean = 20.96, range = 14-35). BDI-II scores did not fluctuate between the prescreen and the first test session to the extent that they no longer fit the ranges outlined above.
Stimuli
Three hundred and sixty images were selected from the International Affective Picture System (IAPS; Lang, Greenwald, Bradley, & Hamm, 1993) . IAPS images range from photographs depicting happy relationships, to everyday scenes, to images of injury and violence, and each are rated on nine-point scales for emotional valence (1 = negative, 5 = neutral, 9 = positive) and arousal (1 = calm, 9 = exciting). Images were selected based on their valence and arousal ratings, and placed into one of three emotion categories: "positive", "neutral" or "negative", each of which contained 120 images. Pairwise comparisons demonstrated that there was a significant difference in the mean IAPS valence rating (i.e. normative valence ratings from the IAPS database) between all emotion categories (positive: [7.31 ± 0.04; mean ± SEM], neutral: [5.04 ± 0.02], negative: [2.42 ± 0.05]; all pairwise p < .001). There was also a significant difference in the mean IAPS arousal rating (i.e. normative arousal ratings from the IAPS database) for the neutral category relative to the positive and negative categories (positive: [5.5 ± 0.06], neutral: [3.33 ± 0.06], negative: [5.5 ± 0.06]; both p < .001), however we ensured that there was no significant difference in the mean normative arousal rating between the positive and negative categories [p = .886] .
Selected images were divided into two equal sets of 180 (60 positive, 60 neutral, 60 negative), which were matched as closely as possible for IAPS valence and arousal ratings. During learning phases, each participant viewed one of these two sets of images which served as the targets during subsequent recognition tests (see Section 2.4 for details regarding learning phases and recognition tests). Each of the two sets of 
Experimental protocol
The experimental protocol is summarised in Fig. 1 . Participants took part in one of two experimental conditions, a SD condition or a NS condition. All participants arrived at the Lincoln Sleep and Cognition Laboratory at 8 PM. The study protocol began with participants completing the BDI-II and the Pittsburgh Sleep Quality Index (PSQI; a selfreport measure of subjective sleep quality over the last month; Buysse, Reynolds, Monk, Berman, & Kupfer, 1989) . This was immediately followed by a learning phase and immediate recognition test (see Section 2.4 for details) which lasted approximately 1 h in total. Participants assigned to the NS group then returned home where they were asked to be in bed from 10.30 PM to 7.30 AM and to sleep normally, before returning to the laboratory at 8 AM the following morning. This group of participants recorded their sleep using portable, in-home PSG devices (Sleep Profiler TM ; Levendowski et al., 2017 ; see Section 2.5.2 for details). Participants assigned to the SD group remained awake in the laboratory under the supervision of the researcher until the following morning. During this time participants were free to eat, drink, read, listen to music, communicate with the researcher, or use the computer. Participants were not permitted to consume alcohol, caffeine, or other drugs during this time.
At 8 AM (12 h after the learning phase) all participants completed a 12 h recognition test which lasted approximately 30 min and provided a measurement of consolidation processes which occurred during the preceding 12 h of sleep or wakefulness. One week after the learning phase, participants returned to the laboratory at 8 PM where they completed a 7 d recognition test which also lasted approximately 30 min. The purpose of this one week follow-up was to examine the impact of SD on long-term consolidation processes. The 7 d recognition test was carried out at the same time of day as the immediate recognition test to control for the impact of circadian rhythms on cognitive performance (Blatter & Cajochen, 2007; Kyriacou & Hastings, 2010) .
Learning phases and recognition tests
The immediate recognition test was administered immediately after the learning phase. Prior to each recognition test participants indicated their level of sleepiness on a scale from one (alert, wide awake) to seven (fighting sleep) using the Stanford Sleepiness Scale (SSS; Hoddes, Dement, & Zarcone, 1972) . The two delayed recognition tests (i.e. 12 h and 7 d) were identical to the immediate recognition test, except that they contained different target and foil images (see Section 2.2 for more information about image sets).
The learning phase and recognition tests are summarised in Fig. 2 . At the beginning of the learning phase participants saw a black screen with a white central fixation cross for 500 ms. They were then presented with the first image (size: 15 cm × 11 cm) for 1000 ms which appeared in the centre of the screen. Following the image, participants were prompted to provide a valence rating for the image on a scale from one (very negative) to nine (very positive) using corresponding keys. Once a valence rating had been submitted, participants were prompted to rate the image for emotional arousal on a scale from one (low arousal) to nine (high arousal). After the arousal rating had been submitted, participants were again presented with the fixation cross followed by the second image. This pattern continued until every image had been viewed and rated. Participants were instructed to provide their emotion ratings quickly and spontaneously, and were informed prior to the learning phase that their memory for the images would be tested immediately after learning and again after both 12 h and 7 d.
The recognition tests were identical to the learning phase except that before providing their emotion ratings participants were required to make a remember/ know/ new judgement for the image using corresponding keys (i.e. R, K or N). For the R/K/N procedure, participants were instructed to provide a remember (R) response if they could consciously recollect seeing that specific image during the prior learning phase. They were asked to provide a know (K) response if they felt the image was familiar, but they could not consciously recollect details about its previous occurrence. They were asked to press the new (N) key if they felt that they had not seen the image during the prior learning phase. These instructions were presented both orally and as text on the computer monitor before the task commenced. A "remember" response indicates recollection of the episodic details of an item, whereas a "know" response reflects item familiarity in the absence of recollection (Mickley & Kensinger, 2008) ; these different forms of remembering are thought to be supported by different neural processes (Dobbins, Kroll, & Yonelinas, 2004; Yonelinas, 2002) . For this study, we were particularly interested in examining remember responses (see Section 2.6.1 for more information). Participants were asked to provide their memory judgements as quickly and accurately as possible. There was no time constraint for memory judgments or emotion ratings in the learning phase or recognition tests. Fig. 1 . Pictorial representation of the study protocol. Participants in the SD condition began a learning phase at 8 PM which was followed by an immediate recognition test. They then remained awake in the laboratory until 8 AM the following morning, before completing a 12 h recognition test. Participants in the NS condition began a learning phase at 8 PM which was followed by an immediate recognition test. They then returned home to sleep normally between 10.30 PM and 7.30 AM, before returning to the laboratory for a 12 h recognition test at 8 PM. These participants recorded their sleep using a Sleep Profiler™ In-home EEG Sleep Monitor. Participants in both conditions returned to the laboratory at 8 PM, one week after the learning phase, to complete a 7 d recognition test. Abbreviations: PSG, Polysomnography; SD, Sleep Deprivation; NS, Normal Sleep.
Equipment
Experimental task
Stimulus presentation and data collection used custom-written scripts running in SuperLab 5™ (Cedrus Corp, San Pedro, CA) on a Windows desktop computer with a 15.6″ screen. Participant responses were recorded using the computer keyboard.
Polysomnography
Overnight sleep monitoring of participants in the NS group was carried out in the homes of participants using a Sleep Profiler™ in-home EEG Sleep Monitor, which provides data comparable to lab-based PSG (Lucey et al., 2016) . Disposable electrodes were attached at two standard locations according to the international 10-20 system (Homan, Herman, & Purdy, 1987) : Fp1 and Fp2, as well as upper and lower chin electromyogram and a reference electrode placed at Fpz. All electrodes were verified to have a connection impedance of < 5000 Ω. All signals were digitally sampled at a rate of 256 Hz.
Data analysis 2.6.1. Behavioural data analysis
Although our experimental task provided an index of both recollection (R responses) and familiarity (K responses) recognition performance (see Fig. 2 ), we were particularly interested in recollection as this has previously shown emotion-specific sensitivity to sleep (Cairney et al., 2015; Harrington et al., 2018) . Therefore, we made this the primary focus of this manuscript. Nonetheless, analyses pertaining to familiarity recognition performance, and combined recollection and familiarity recognition performance, are available in Supplement 1 and Supplement 2, respectively.
Data from recollection trials were first converted to d′ scores (d′ = Z (hits/hits + misses) -Z (false alarms/false alarms + correct rejections); extreme proportions of zero or one were replaced with values of "1/ (2N)" and "1-1/(2N)", respectively, where N equals the number of trials upon which the proportion is based; Macmillan & Kaplan, 1985) , a signal detection process widely used in memory studies to account for response bias (Macmillan & Creelman, 2004) . This was done separately for positive, neutral and negative image trials for each participant. In accordance with previous research (Cairney et al., 2015; Groch et al., 2015; Nishida et al., 2009) , to measure the time course of memory consolidation we created a difference measure, which we refer to as 'behavioural consolidation', by subtracting d′ scores at immediate recognition testing from d′ scores at 12 h and 7 d recognition testing. The resulting behavioural consolidation scores provide indices of the emotional memory processes taking place across the 12 h and 7 d retention intervals, respectively.
Our main analysis used a two (depressive symptomatology group: higher BDI-II score group, low BDI-II score group) × two (sleep condition group: SD, NS) × three (image valence: positive; neutral; negative) mixed-measures ANOVA with behavioural consolidation as the dependent variable. Our primary hypothesis was that there would be a significant three-way 'depressive symptomatology group' × 'sleep condition group' × 'image valence' interaction, driven by impaired consolidation of negative images in the higher BDI-II score SD group.
Sleep data analysis
Each participant's sleep data was divided into 30 s epochs and scored manually by trained sleep researchers using REM Logic© 1.1 according to the AASM standardised criteria (Iber, Ancoli-Israel, Chesson, & Quan, 2007) . Sleep data was scored from a channel created by referencing Fp1 to Fp2 (for more information see: Lucey et al., 2016) . This gave the duration and proportion of each sleep stage (N1, N2, SWS, and REM), as well as measures of sleep efficiency and total sleep time.
Results
Participant demographics
The participants' demographic characteristics are shown in Table 1 . To compare demographic characteristics between depressive Fig. 2 . Pictorial representation of the learning phase and recognition tests. During learning phases and recognition tests participants were required to rate each image on a scale from one to nine in terms of emotional valence (1 = very negative, 9 = very positive) and emotional arousal (1 = low arousal, 9 = high arousal). During recognition tests, participants were additionally required to provide remember (R), know (K), or new (N) response. symptomatology groups (higher BDI-II score group, low BDI-II score group) we conducted independent-samples t-tests, which confirmed that the higher BDI-II score group had significantly higher BDI-II scores than the low BDI-II score group [t(52) = 16.18, p < .001]. The higher BDI-II score group also reported significantly higher PSQI scores than the low BDI-II score group [t(52) = 6.08, p < .001], indicating poorer sleep quality in the higher BDI-II score group, as expected (Baglioni et al., 2011; Palagini, Baglioni, Ciapparelli, Gemignani, & Riemann, 2013) . There was no significant age difference between the two depressive symptomatology groups [t(52) = 0.88, p = .382].
To examine whether demographic characteristics differed between sleep condition groups (i.e. SD group, NS group), the independentsamples t-tests reported above were repeated, this time comparing sleep condition groups, separately for each depressive symptomatology group (i.e. higher BDI-II score group, low BDI-II score group). There was no significant difference between the SD group and the NS group in BDI-II score, PSQI score, or age in either the higher BDI-II score group [all p ≥ .668] or the low BDI-II score group [all p ≥ .374]. These results suggest that between-sleep condition group differences in depressive symptom severity, sleep quality or age can reasonably be discounted as a source of variability in recognition performance.
Alertness
Subjective sleepiness scores are shown in To explore the interaction between time and sleep condition, we compared SSS scores between the two sleep conditions, separately for each recognition test (immediate, 12 h, 7 d), using independent-samples t-tests. It was revealed that relative to the NS condition, participants in the SD condition reported significantly greater subjective sleepiness before the 12 h recognition test [t(52) = 5.59, p < .001]. There was no difference in SSS scores between the two sleep condition groups before the immediate recognition test [t(52) = 0.72, p = .473] or the 7 d recognition test [t(52) = 1.01, p = .316]. These results confirm that, unsurprisingly, participants in the SD group felt more tired before the 12 h recognition test, following a night of SD. Importantly, however, there was no correlation between 12 h SSS scores and behavioural consolidation of positive, neutral or negative images for participants who completed the SD condition [all p ≥ .490], suggesting that decreased subjective alertness is unlikely to underlie any betweencondition differences in recognition performance.
Sleep parameters
Sleep parameter data obtained from the higher BDI-II score NS group and the low BDI-II score NS group are shown in Table 3 . To compare sleep parameters between the two depressive symptomatology groups in the NS condition we conducted independent-samples t-tests on total sleep time, sleep efficiency, and duration and proportion of sleep stages N1, N2, SWS and REM. It was revealed that there was no significant difference between the two depressive symptomatology groups in any of these sleep parameters [all p ≥ .124]. These results suggest that sleep structure on the night of testing was comparable between participants with higher BDI-II scores and participants with low BDI-II scores. Correlational analyses examining the relationship between sleep parameters and post-sleep recognition performance are available in Supplement 3.
Subjective ratings of valence and arousal
Subjective valence and arousal ratings obtained from participants during the learning phase of this study are shown in Table 4 . The subjective valence and arousal ratings provided by six participantsfour from the low BDI-II score SD group, one from the higher BDI-II score NS group, and one from the low BDI-II score NS group -were not recorded due to a technical fault. The valence and arousal ratings obtained from the remaining participants during the learning phase were analysed using two (depressive symptomatology group: higher BDI-II Conflicting findings exist regarding the effects of sleep, and sleep deprivation, on changes in subjective emotional reactivity (for review see: Tempesta, Socci, De Gennaro, & Ferrara, 2017) . Accordingly, we sought to investigate whether the sleep condition groups and depressive symptomatology groups in this study differed with regard to their change in valence and arousal ratings between the encoding session and each of the recognition tests. These analyses are reported in Supplement 4. Briefly, changes in emotionality ratings between the encoding and recognition tests were not influenced by depressive symptomatology group, sleep condition or image valence, and there were no interactions between these factors.
Immediate recognition performance
As described in Section 2.6.1, the results presented in this section focus exclusively on recollection responses. Immediate recognition performance data is available in Table 5 . For unstandardized hit-rates and false alarm-rates at immediate recognition see Supplement 5.
To test for any effects of depressive symptomatology group, sleep condition group, or image valence on immediate recognition performance we conducted a two (depressive symptomatology group: higher BDI-II score group, low BDI-II score group) × two (sleep condition group: SD group, NS group) × three (image valence: positive, neutral, negative) mixed-measures ANOVA on immediate recognition scores (d′). The analysis showed a significant main effect of image valence [F (2, 98) = 3.46, p = .035, η p 2 = 0.066], which was driven by significantly greater recognition performance for neutral images (3.92 ± 0.11) relative to positive images (3.60 ± 0.12) [t(53) = 2.94, To investigate the effect of depressive symptomatology group, sleep condition group, and image valence on memory consolidation we performed a two (depressive symptomatology group: higher BDI-II score, low BDI-II score) × two (sleep condition group: SD group, NS group) × three (image valence: positive, neutral, negative) mixedmeasures ANOVA on behavioural consolidation scores. This was done separately for behavioural consolidation at 12 h and 7 d. Mean-centered PSQI score was included as a covariate in these analyses. In accordance with the hypothesis, we found a significant three-way interaction between depressive symptomatology group, sleep condition, and image valence on 12 h behavioural consolidation scores [F(2, 98) = 3.12, p = .049, η p 2 = 0.060]. This interaction was also marginally significant To test our hypothesis that SD would impair the consolidation of negative memories in participants reporting mild-to-severe depressive symptoms, we performed a priori independent-samples t-tests comparing behavioural consolidation scores at 12 h between sleep condition groups for participants in the higher BDI-II score group, separately for each image valence. In further support of our hypothesis, it was revealed that the higher BDI-II score NS group exhibited significantly greater behavioural consolidation of negative images at 12 h, relative to the higher BDI-II score SD group [t(24) = 2.35, p = .028]. The t-tests also showed significantly greater behavioural consolidation of neutral images at 12 h in the higher BDI-II score NS group, relative to the higher BDI-II score SD group [t(24) = 2.79, p = .010]. Notably, neither of these effects were observed in the low BDI-II score group [both p ≥ .447]. However, an additional a priori t-test showed that the low BDI-II score NS group consolidated significantly more positive memories than the low BDI-II score SD group [t(26) = 2.14, p = .042]. The consolidation of positive images was not influenced by sleep condition for participants in the higher BDI-II score group [t(24) = 0.13, p = .895]. These findings suggest that SD may impair the consolidation of negative and neutral memories for participants reporting mild-tosevere depressive symptoms. To examine differences in sleep-and sleep deprivation-related consolidation between the two depressive symptomatology groups we conducted a two (depressive symptomatology group: higher BDI-II score group, low BDI-II score group) × three (image valence: positive, neutral, negative) mixed-measures ANOVA on 12 h behavioural consolidation, separately for each sleep condition group. Mean-centered PSQI score was included as a covariate in these analyses. The analysis revealed a marginally significant depressive symptomatology group × image valence interaction in the NS condition [F(2, 46) = 2.55, p = .089, η p 2 = 0.100], which was driven by greater consolidation of positive images in the low BDI-II score NS group, relative to the higher BDI-II score NS group [t(24) = 2.13, p = .043]. The ANOVA revealed no other significant main effects or interactions [all p ≥ .153].
Discussion
We investigated the effect of sleep, and SD, on the consolidation of emotionally positive, neutral and negative images in participants reporting either mild-to-severe depressive symptoms or minimal/no depressive symptoms. We hypothesized that SD would impair the consolidation of negative emotional memories, particularly in the higher BDI-II score group. Offering some support to our hypothesis, we found that a night of SD, relative to a night of sleep, significantly impaired the consolidation of negative and neutral images after 12 h in participants reporting mild-to-severe depressive symptoms. Importantly, these effects were not observed in participants reporting minimal/no depressive symptoms.
Research has shown that in healthy participants overnight sleep supports the consolidation of negative emotional memories, relative to an equal duration of daytime wakefulness (Payne et al., 2008) or overnight SD (Tempesta et al., 2015) . However, to our knowledge, our results are the first to demonstrate that the detrimental effect of SD on the consolidation of negative and neutral memories is more robust in participants reporting mild-to-severe depressive symptoms than participants reporting minimal/no depressive symptoms.
A multitude of recent studies in healthy participants have demonstrated the active and selective role of REM sleep in the processing and consolidation of negative emotional memories (Groch et al., 2015; Nishida et al., 2009; Payne et al., 2012; Wagner et al., 2001; Wiesner et al., 2015) . REM sleep is thought to support the consolidation of emotionally salient memories through the reactivation of, and coherence between, neural regions implicated in emotional memory processing during wake, in particular the amygdala, entorhinal cortex and medial prefrontal cortex (Hutchinson & Rathore, 2015; Maquet et al., 1996; Nir & Tononi, 2010) . By inhibiting this pattern of neural activation associated with REM sleep, SD may have impaired the processing and consolidation of negative emotional images in this study. Indeed, a recent study found that healthy students selectively deprived of REM sleep exhibited significantly less overnight consolidation of negative emotional images, relative to participants selectively deprived of SWS (Wiesner et al., 2015) , supporting the interpretation that REM sleep suppression, rather than SD per se, impaired the consolidation of negative emotional images in this study. Importantly, however, this interpretation alone does not explain why the detrimental effect of SD on negative emotional memory consolidation in the higher BDI-II score group was absent in the low BDI-II score group.
One possible explanation for this effect is that REM sleep facilitated emotional memory consolidation more readily in the higher BDI-II score group than the low BDI-II score group. Indeed, in a recent study we found that the consolidation of emotional memories during REM sleep was greater in participants reporting mild-to-moderate depressive symptoms than participants reporting minimal/no depressive symptoms . However, in this study, negative memory consolidation did not differ significantly between the higher BDI-II score NS group and the low BDI-II score NS group. In addition, no relationship was observed between REM sleep duration and recognition performance for negative images in either depressive symptomatology group (see Supplement 3). Further research including larger sample sizes are required to understand why the detrimental effect of SD on negative emotional memory consolidation, relative to a night of sleep, is more robust in participants reporting greater depressive symptoms. Moreover, additional experiments are required to investigate whether this effect is specifically linked to REM sleep. Such studies will benefit from the inclusion of a selective REM SD condition, and a sleep group that sleeps in the laboratory under constant observation by a researcher. Both conditions should include a comprehensive polysomnographic assessment. Moreover, the current study lacks a control group wherein which the participants are tested individually to prevent interactions among participants which could have influenced the results.
Besides our hypothesis-related finding that SD impaired the consolidation of negative emotional images in our higher BDI-II score group, our data also showed that SD, relative to a night of sleep, impaired the consolidation of neutral images in our higher BDI-II score group after 12 h. Considering the plentiful evidence that SWS is critically involved in the consolidation of hippocampus-based, emotionally neutral declarative memories (Stickgold, 2005) , this finding is not surprising. However, it is unclear why this effect was found in our higher BDI-II score group, and not in our low BDI-II score group, especially considering that sleep-related consolidation of emotionally neutral memories has been shown to be impaired in MDD patients (Dresler et al., 2011 (Dresler et al., , 2010 Göder et al., 2007; Nishida et al., 2016) . Intriguingly, however, although overnight motor memory consolidation was impaired in MDD patients relative to controls in the Nishida et al. (2016) study, it was reported that greater SWS duration predicted greater consolidation in participants with MDD, but not control participants (Nishida et al., 2016) . These findings corroborate a recent study of ours, which showed that SWS supported the consolidation of neutral images more readily in individuals reporting mild-to-moderate depressive symptoms than individuals reporting minimal/no depressive symptoms . These findings suggest that the consolidation of neutral memories may be more dependent on SWS in depressive individuals, and explains why SD, relative to a night of sleep, had a detrimental effect on the consolidation of neutral images in our higher BDI-II score group but not our low BDI-II score group. However, it is important to consider that the differences in neutral memory consolidation between the NS and SD groups may not be related specifically to SWS. Similarly, REM sleep in particular may not subserve differences in negative memory consolidation. Indeed, both effects could be related to the same process.
Our results also showed that overnight sleep supported the consolidation of positive memories more readily in the low BDI-II score NS group than the higher BDI-II score NS group. The effect of sleep on the consolidation of positive images has been scarcely investigated, (however, see : Cairney, et al., 2015; Harrington et al., 2018; Sterpenich et al., 2007) so it is difficult to explain why sleep consolidated positive memories more effectively for individuals reporting minimal/no depressive symptoms. One plausible explanation for this effect relates to the mechanisms underlying emotional memory encoding. It has been proposed that the amygdala activity elicited by encoding an emotional memory may act as an 'emotional tag', leading to the prioritised consolidation of these memories during subsequent sleep intervals (Bennion, Payne, & Kensinger, 2015) . Neuroimaging research reveals that healthy participants exhibit greater amygdala responses to positive stimuli (masked happy human facial expressions) than MDD patients (Stuhrmann et al., 2013; Suslow et al., 2010) . In this study, the positive images may have elicited greater amygdala activity in the low BDI-II score group than the higher BDI-II score group, which led to greater consolidation of positive images during sleep in the low BDI-II score group. Further research employing fMRI is required to confirm this interpretation.
In sum, the behavioural consolidation data obtained from this study suggests that for participants reporting mild-to-severe depressive symptoms, sleep preferentially preserved memory for negative and neutral items. Conversely, memory for positive items was preserved across a night of sleep, relative to a night of SD, for participants reporting minimal/no symptoms of depression. Although SD did not exclusively suppress the consolidation of negative images in the higher BDI-II score group (i.e. the consolidation of neutral images was also impaired), the ability of SD to prevent negative memory consolidation in these individuals may have implications for our understanding of SD therapy in MDD.
Implications
Growing clinical evidence supports the efficacy of SD therapy as an antidepressant intervention for MDD (for reviews see: Benedetti & Colombo, 2011; Wu & Bunney, 1990) . Remarkably, SD has been reported to produce a clinical improvement in depressive symptoms within a single 24 h period for approximately 60% of MDD patients (Berger, van Calker, & Riemann, 2003; Leibenluft & Wehr, 1992; WirzJustice & Van Den Hoofdakker, 1999; Wu & Bunney, 1990) . However, this effect is typically transient, with approximately 80% of SD responders experiencing a return of depressive symptoms following subsequent recovery sleep or daytime naps (Riemann, Wiegand, Lauer, & Berger, 1993) .
Several researchers have attempted to explain the neurobiological basis of this phenomenon (e.g. Brunner, Dijk, & Borbély, 1993; Wolf et al., 2016; Wu & Bunney, 1990) , however, no consensus has been reached on the mechanisms underlying the therapeutic effect of SD in MDD. Nonetheless, in accordance with the predictions of our Affect Tagging and Consolidation (ATaC) model (Harrington, Pennington, & Durrant, 2017) , we propose that SD may improve depressive symptoms by suppressing the processing and consolidation of negative emotional memories which typically occurs during REM sleep (Groch et al., 2015; Nishida et al., 2009; Payne et al., 2012; Wagner et al., 2001; Wiesner et al., 2015) . Our finding that SD significantly impairs the consolidation of negative emotional images in participants reporting mild-to-severe depressive symptoms may provide some support for this notion. However, given that we utilized the BDI-II as our measure of depressive symptom severity, which assesses depressive symptoms over the preceding two weeks, it is impossible to determine whether the suppression of negative emotional memory consolidation was associated with improvements in depressive symptoms in this study. It is of course plausible that the impaired emotional memory consolidation elicited by SD in the higher BDI-II score group represents an effect which is independent of the therapeutic response to SD observed in MDD patients. Future research is required to examine whether impairments in negative emotional memory consolidation associated with SD, relative to a night of sleep, correlate with improvements in depressive symptoms. Such studies will require the use of clinically depressed MDD patients (confirmed using structured clinical interview for DSM-5; SCID-5) and measures of current depression severity that are sensitive to changes across a single SD interval such as self-ratings and external ratings from psychiatrists who are blind to the experimental conditions (e.g. Elsenga & van den Hoofdakker, 1982) .
In addition to elucidating the mechanisms underlying SD therapy in MDD, such research may also improve our understanding of the mechanisms of action of several antidepressant medications. It is well reported that most antidepressant drugs considerably inhibit REM sleep, thus increasing REM sleep latency or decreasing REM sleep density and duration (Mayers & Baldwin, 2005; Murck et al., 2003; Palagini et al., 2013; Steiger & Kimura, 2010; Thase, 2006; Vogel, Buffenstein, Minter, & Hennessey, 1990) . This finding lead researchers to propose that REM sleep suppression may be an essential component of any effective form of MDD therapy (Vogel, McAbee, Barker, & Thurmond, 1977) . However, this notion is contested by studies which report that a few pharmaceuticals effective in the treatment of MDD such as the tricyclic antidepressant trimipramine, the norepinephrine-dopamine reuptake inhibitor bupropion, and the serotonin reuptake enhancer tianeptine, do not inhibit REM sleep (Murck et al., 2003; Nofzinger et al., 1995; Sonntag et al., 1996) . Although it is clear that REM sleep suppression is not an exclusive mechanism by which antidepressants improve depressive symptoms, the effect of pharmaceuticals which inhibit REM sleep on the overnight consolidation of negative emotional memories is certainly one possible mechanism.
Limitations
Our analyses of SSS scores revealed that during the 12 h recognition test, participants in the SD group reported greater subjective sleepiness than participants in the NS group. Whilst this finding was expected, it could be argued that the emotion-specific effects of SD on memory consolidation were due to reduced alertness, rather than reduced sleepdependent memory consolidation. However, there is no inherent reason for tiredness in SD to impair negative and neutral but not positive memory, so we do not believe this is the most parsimonious explanation of our results. Indeed, 12 h SSS scores did not correlate with 12 h behavioural consolidation of positive, neutral or negative images for participants who completed the SD condition.
Similarly, it is plausible that the data from our 12 h recognition test may have been influenced by the effect of circadian rhythms on cognitive performance and memory formation (Gerstner, & Yin, 2010; Schmidt, Collette, Cajochen, & Peigneux et al., 2007) . Although we carried out the 7 d recognition test at the same time of day as the immediate recognition test, it would have been impossible to match for time of day between the immediate recognition test and the 12 h recognition test without depriving our participants of a further 12 h of sleep. Nonetheless, as both groups were tested at the same time of day throughout the study, circadian effects cannot easily explain the differences we see between groups.
Our t-tests revealed significant differences in behavioural consolidation for negative and neutral images between the SD and NS higher BDI-II score groups. However, it is important to note that no significant interaction was found in the preceding sleep condition × image valence ANOVA. Accordingly, the finding that SD impairs the consolidation of negative and neutral memories in participants reporting depressive symptoms should be regarded as preliminary, as opposed to solid empirical evidence. Further studies utilizing larger sample sizes are required to ascertain the impact of SD on emotional memory consolidation in depressive participants.
Finally, between-group comparisons of our two depressive symptomatology groups revealed that sleep quality in the month preceding the first session was significantly lower in the higher BDI-II score group, relative to the low BDI-II score group. This result is unsurprising, considering that sleep disturbances are reported by up to 90% of MDD patients (Baglioni et al., 2011; Palagini et al., 2013) . Importantly, sleep quality has been shown to influence emotional memory processing (Tempesta et al., 2015) . Nevertheless, we see differences between our two higher BDI-II score groups which cannot be due to these differences in sleep quality. Moreover, we included PSQI score as a covariate in our analyses where appropriate, ensuring that our findings were not confounded by between-group differences in sleep quality.
Conclusion
Our study has shown that a night of SD, relative to a night of sleep, significantly impairs the consolidation of negative and neutral images after 12 h in participants reporting mild-to-severe depressive symptoms. Notably, these effects were not found in participants reporting minimal/no depressive symptoms. Our findings may support the notion that the antidepressant response to SD in MDD is related to the suppression of REM sleep-related negative emotional memory processing and consolidation (Harrington et al., 2017) . Further research including larger sample sizes, MDD patients, and a more clinically robust measure of depressive symptom severity should examine whether the suppression of negative emotional memory consolidation associated with a night of SD, relative to a night of sleep, correlates with improvements in depressive symptoms.
